Saffron as antidepressant and saffron to prevent and cure side effects of common antidepressants. Saffron against burnout, anxiety attacks, gluttony, OCD, …
For many years I am using several Amanprana products. My all-time favorites are Kotobuki Matcha, Gula Java Cacao, Gula Java Safran, Coconut Oil, Botanico Mix and Razoli.Marco Zielinski, Geschäftsführer, Rhino's energy GmbH, Germany
More people suffer from depression than ever before Anxiety, constipation, suicidal thoughts, sleeplessness, …
In the West 1 in 10 adults say that they suffer from depression. By 2020 depression is expected to be the world’s biggest cause behind an inability to function (2).
Billions spent on modern psychopharmacology annually: antidepressants. Their use continues to rise, Americans are top of the list with 11% of the population taking antidepressants (4).
The tragedy? Around 90 % of these patients experience at least one of the numerous serious side effects (5)(6)(7)(8)(9)(10) – such as anxiety, constipation, suicidal thoughts, sleeplessness, putting on weight (6)7)(8)(9)(10) and sexual disorders. Also, the association between using antidepressants during pregnancy and the risk of autism for the child (11) is great. As many as 73 % of the people who take antidepressants will end up suffering from sexual disorders (10). Antidepressants often lose their effectiveness in the course of the treatment, but the sexual disorder frequently continues for years to come (9).
In an attempt to prevent side effects, a lot of people are now looking for alternatives (13).
In this article we are disclosing new findings, which demonstrate that saffron (Crocus sativus) is just as effective as certain modern-day medications in the treatment of depression, but without the undesirable side effects (14)(15). There are also sufficient indications that - when saffron is added to an existing treatment with antidepressants - it works as a powerful complementary therapy to block the undesirable sexual effects (16)! Saffron can also be used in cases of anxiety and obsessive and compulsive disorders, which are often helped with antidepressants.
Saffron to boost your mood.
Goodbye depression, goodbye burnout! Goodbye antidepressants!
In Persian traditional medicine saffron was already used against depression (17). This early use led to the contemporary research into the influence of saffron on our mood. Research since 2001 shows that saffron extract possesses clear anti-depressant properties (18). These tests were however always carried out on mice.
In 2010 scientists carried out a scientifically conclusive double-blind, randomised, clinical study on humans in order to compare saffron with a placebo. 40 adult outpatients were diagnosed as suffering from severe depression according to the Diagnostic and Statistical Manual of Mental Disorders. After 6 weeks the saffron subjects demonstrated considerably better results on the Hamilton Depression Rating Scale than the placebo subjects. The effectiveness of Crocus sativus (saffron) in the treatment of mild to moderate depression (17) was also proved on humans. No significant side effects were reported. Subsequently scientists searched for the effectiveness of saffron in comparison with a lot of common antidepressant medication. Could saffron be just as effective against depression as medicine?
Saffron effective in the treatment of depression, without the undesirable side effects
Saffron better than Tofranil (Imipramine)
In a double-blind single-centre study, scientists randomly divided 30 depressed patients into two groups. One group took a 30mg capsule of saffron three times a day; the other group took 100mg of Tofranil three times a day. All the subjects satisfied the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, criteria for severe depression (14). Just 6 weeks later, the dose of saffron was demonstrated to be just as effective as Tofranil in the treatment of mild to moderate depression. The Tofranil group was the only one to suffer from anticholinergic symptoms, such as a dry mouth (an anticholinergic blocks the neurotransmitter acetylcholine in the nervous system) and considerable, undesired sedation. The author of the study came to the conclusion “that saffron has a therapeutic advantage in the treatment of mild to moderate depression in relation to Tofranil" (14).
Saffron just as good as Prozac (Fluoxetine)
Forty adult outpatients who satisfied the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (criteria for depression) were randomly assigned to a group which took a 30mg capsule of saffron pistils twice a day or else to the group which took one 20mg capsule of Prozac twice a day (15). At the end of the 6 week long, double-blind, randomised study saffron was found to be just as effective as Prozac in the treatment of mild to moderate depression. There weren’t any significant differences in undesired reactions. (15).
These studies clearly show that saffron is a powerful alternative to commonly prescribed antidepressants for the treatment of depression, but then without side effects. But saffron is also perfect for the treatment of other emotional cognitive disorders, without side effects!
In spite of their name antidepressants are used to treat more than just depression. They are used for a broad range of other emotional and cognitive complaints such as obsessive-compulsive disorder, anxiety and Alzheimer’s (19)(20)(21)(22).
Some scientists reasoned that - as saffron is just as effective against depression as antidepressants – saffron is probably also a safer treatment for those other disorders which are often treated with antidepressants. Surprisingly it now appears that, when saffron is added to the treatment of male and female patients who already take antidepressants, the negative sexual side effects of the antidepressant are reduced!
Saffron effective in treatment of anxiety attacks
Anxiety can be crippling and almost 30% of the Western population has had to deal with the symptoms of severe anxiety at one time in their life (27). Selective serotonin reuptake inhibitors (SSRIs) are often recommended for the treatment of anxiety disorders (20) and social anxieties (21). They come with a range of negative side effects, from nausea to sexual disorders (6)(7)(8)(9).
Fortunately animal studies have come up with a powerful and safe alternative: they demonstrate that saffron, and more particularly the active components 'crocin' and 'safranal' reduce anxiety attacks, without harmful side effects (28)(29).
Saffron effective with obsessive-compulsive disorder (OCS)
An obsessive-compulsive disorder (OCS) can be so serious that patients devote pretty much all of their time to their obsessions and compulsiveness (30). In the majority of cases antidepressants are tried out first, in an attempt to control the time-consuming and stressful symptoms (22) of an obsessive-compulsive disorder. It is not unusual for different medicines of different doses to be tried out, before any amount of control of the symptoms can be achieved (22). Finally, almost always different medicines are combined (22), which can result in several levels of negative symptoms which can considerably counteract positive advantages.
Studies show that there is an interaction between crocin in saffron and the serotonergic (the neurotransmitters which are responsible for serotonin secretion) in medication (31). A study demonstrated that crocin can considerably reduce obsessive-compulsive disorder symptoms without any significant negative side effects (31).
Saffron effective in treating gluttony and uncontrollable eating
Obesity has become an epidemic. The disorder, which is also known as reactional gluttony, or reactional polyphagia, is also responsible for uncontrollable snacking and eating (33). Obesity is related to an imbalance in the neurotransmitters and a particularly low level of serotonin. Stress, vulnerability and a disordered brain increase your urge for food and overeating (32). You reward yourself with snacking and uncontrollable eating (34)(35)(36)(37).
Unfortunately appetite depressant medicines often have dangerous side effects: heart valve damage, birth defects, liver damage and increased blood pressure, and sometimes even fatal consequences (38).
Scientists launched a randomised, double-blind, placebo-controlled clinical study with 60 slightly overweight women at least half of whom were judged to be suffering from a form of compulsive snacking between meals. After 8 weeks the number of snacks in the saffron group had gone down by 28 % and 55 % reported a reduced need to snack (37)! After 8 weeks and without a diet, the saffron group had on average lost 2 kilos and reported increased energy and reactions (37). This weight loss demonstrates how you can lose weight in a meaningful way by cutting down on snacking.
Antidepressants cause serious side effects in more than 50% of patients.
Saffron offers a healthy solution.
Even though antidepressants are associated with a broad range of negative reactions (6)7)(8)(9)(10) negative sexual side effects, in particular, can be frustrating. As negative sexual side effects the loss of sexual drive, inability to reach orgasm and erectile dysfunction were mentioned. (9)(10).
These undesirable sexual symptoms are often underestimated (10). However research demonstrates that sexual dysfunction with selective serotonin reuptake inhibitors (SSRIs) and Effexor (Venlafaxine) affects between 58 and 73 % of people on antidepressants (10)! And these sexual symptoms can continue long after you stop taking the medication - months, years, or even for an indefinite period (9)! Unfortunately people who suffer from depression have often struggled with different antidepressants for years, before they could finally lead a stable life with a specific dose of a specific medicine. Doctors and patients are as a consequence reluctant to change their regime ‘simply’ to prevent or cure the sexual complaints (40)(41)(42). Instead of this doctors often prescribe complementary medicines (43)(44)(45)(46)(47). However, these complementary medicines all have negative side effects of their own (45)(46)(47)(48).
In the meantime scientists have discovered that saffron doesn’t just work as an antidepressant but can also have positive effects on the sex life as an aphrodisiac. Studies on humans and animals have demonstrated this (16)(49)(50)(51).
Saffron blocks the negative sexual side effects of antidepressants!
In autumn 2012, a randomised, double-blind trial was carried out on 36 married men with a depressive disorder, the symptoms of which were successfully stabilised with Prozac, but who complained of sexual disorders. They were randomly assigned to a group to take, alongside their usual dose of Prozac, 2x15mg saffron per day or 2x15mg placebo per day. Sexual function was determined with the aid of a standard index (16). After 4 weeks the men in the Prozac plus saffron group had significantly less erectile dysfunctions and better sexual intercourse than the Prozac plus placebo group. The team concluded that "saffron is an acceptable and effective treatment for male sexual disorders caused by Prozac" (16).
In 2013 38 women were studied, all of whom had severe depression and were stabilised on Prozac, but continued to suffer from various sexual disorders caused by this antidepressant. In a double-blind study half the women were randomly assigned a 30mg/day supplement of saffron extract. The other half were given a placebo. All participants continued to take their usual dose of Prozac. The evaluations were made with the aid of the Female Sexual Function Index (FSFI) (49). After 4 weeks the women in the saffron-group experienced a considerable improvement in the total sexual function (FSFI), excitement, lubrication and pain (49), in spite of the fact that all took the same antidepressant that had caused the undesirable sexual symptoms. Clearly: saffron offers a powerful, additional therapy for the treatment of the sexual side effects of antidepressants.
All the side effects of antidepressantsThere are 119 published studies from twelve countries, as well as 99 notices on medicines from 10 countries which all indicate that antidepressants can cause the following undesirable effects (6)(7)(8)(9)(10)(70): abnormal bleeding or bruising, abnormal thoughts, agitation, aggression, serious agitation, anxiety, birth defects, black tongue, blurred vision or changes in vision, coma,
confusion, constipation, cramps, intense pain in the breast, death, reduced memory or concentration, delirium, delusions, depression, diabetes, diarrhoea, difficulty breathing or swallowing, dizziness or fainting, dry mouth, emotional numbing, extreme restlessness, fainting, hallucinations, headache, falling heart rate, heart attacks, homicidal thoughts or actions, animosity, hyperactivity, hypomania, sleeplessness, lethargy, liver problems, low white blood cell count, mania or manic reactions, loss of memory, mood swings, muscle spasms, nausea, nervousness, malignant neuroleptic syndrome, night sweats, nightmares, numbness in arms, panic attacks, paranoia, priapism, premature births, psychotic episodes, restlessness, risk of breast cancer, risk of falling, numbness, self-harm, epileptic attacks, serotonin syndrome, severe headache, severe muscular stiffness, sexual dysfunction, unsteadiness, shuffling walk, slow or difficulty with speech, miscarriage, stroke, suicidal thoughts or behaviour, violent behaviour, weight gain, withdrawal symptoms, yellow colouring of the skin or eyes.
Written by Bart Maes
- Available at: http://www.cdc.gov/features/dsdepression/. Accessed April 18, 2013.
- Swartz HA, Rollman BL. Managing the global burden of depression: lessons from the developing world. World Psychiatry. 2003 Oct;2(3):162-3.
- Grundmann M, Kacirova I, Urinovska R. Therapeutic monitoring of psychoactive drugs - antidepressants: A review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. doi: 10.5507/bp.2013.020. Epub 2013 Mar 21.
- Available at: http://www.cdc.gov/nchs/data/databriefs/db76.htm#about. Accessed April 18, 2013.
- Available at: http://www.consumerreports.org/health/resources/pdf/best-buy-drugs/Antidepressants_update.pdf. Accessed April 18, 2013.
- Available at: http://www.cchrint.org/psychiatric-drugs/antidepressantsideeffects/. Accessed April 18, 2013.
- Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011 Aug 2;343:d4551.
- Reynolds GP, Kirk SL. Metabolic side effects of antipsychotic drug treatment—pharmacological mechanisms. Pharmacol Ther. 2010 Jan;125(1):169-79.
- Csoka A, Bahrick A, Mehtonen O-P. Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors. J Sex Med. 2008;5:227-33.
- Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry. 2001;62 Suppl 3:10-21.
- Rai D, Lee BK, Dalman C, Golding J, Lewis G, Magnusson C. Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ. 2013 Apr 19;346:f2059. doi: 10.1136/ bmj.f2059.
- Byrne SE, Rothschild AJ. Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments. J Clin Psychiatry. June 1998;59(6):279-88.
- Freeman MP, Mischoulon D, Tedeschini E, et al. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants. J Clin Psychiatry. 2010 Jun;71(6):682-8.
- Akhondzadeh S, Fallah-Pour H, Afkham K, et al. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot, double-blind randomized trial. BCM Comp Altern Med. 2004;4:12.
- Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi AH. Hydroalcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. J Ethnopharmacol. 2005;97:281-4.
- Modabbernia A, Sohrabi H, Nasehi AA, et al. Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial. Psychopharmacology (Berl). 2012;223(4):381-8.
- Akhondzadeh S, Tahmecebi-Pour N, Noorbala AA, et al. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial. Phytother Res. 2005;19:148-51.
- Karimi G, Hosseinzadeh H, Khaleghpanah P. Study of antidepressant effect of aqueous and ethanolic of Crocus sativus in mice. Iranian J Basic Med Sci. 2001;4:11-5.
- Modrego PJ. Depression in Alzheimer’s disease. Pathophysiology, diagnosis, and treatment. J Alzheimers Dis. 2010;21(4):1077-87.
- Available at: http://www.nice.org.uk/nicemedia/live/13314/52599/52599.pdf. Accessed April 19, 2013.
- Available at: http://www.mayoclinic.com/health/generalized-anxiety disorder/DS00502/DSECTION=treatments-and-drugs. Accessed April 19, 2013.
- Available at: http://www.mayoclinic.com/health/obsessive-compulsive-disorder/DS00189/DSECTION=treatments-and-drugs. Accessed April 19, 2013.
- Available at: http://vitals.nbcnews.com/_news/2013/02/06/ 16872274-alzheimers-numbers-to-triple-by-2050-report-says?lite. Accessed April 19, 2013.
- Banerjee S, Hellier J, Romeo R, et al. Study of the use of antidepressants for depression in dementia: the HTA-SADD trial - a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Health Technol Assess. 2013 Feb;17(7):1-166.
- Akhondzadeh S, Sabet MS, Harirchian MH, et al. Saffron in the treatment of patients with mild to moderate Alzheimer’s disease: a 16-week, randomized and placebo-controlled trial. J Clin Pharm Ther. 2010 Oct;35(5):581-8.
- Akhondzadeh S, Shafiee Sabet M, Harirchian MH, et al. A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease. Psychopharmacology (Berl). 2010 Jan;207(4):637-43.
- Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. Jun 2005;62(6):593-602.
- Pitsikas N, Boultadakis A, Georgiadou G, Tarantilis PA, Sakellaridis N. Effects of the active constituents of Crocus sativus L., crocins, in an animal model of anxiety. Phytomedicine. 2008 Dec;15(12):1135-9.
- Hosseinzadeh H, Noraei NB. Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytother Res. 2009 Jun;23(6):768-74.
- Available at: http://www.mayoclinic.com/health/obsessive- compulsive-disorder/DS00189/DSECTION=symptoms. Accessed April 22, 2013.
- Georgiadou G, Tarantilis PA, Pitsikas N. Effects of the active constituents of Crocus sativus L., crocins, in an animal model of obsessive-compulsive disorder. Neurosci Lett. 2012 Oct 18;528(1):27-30.
- Dye L, Blundell JE. Menstrual cycle and appetite control: implications for weight regulation. Hum Reprod. 1997 Jun;12(6):1142-51.
- Available at: http://www.hyperphagia.com/hyperphagia-causes/. Accessed April 22, 2013.
- Adam TC, Epel ES. Stress, eating and the reward system. Physiol Behav. 2007;91:449-58.
- Alsiö J, Olszewski PK, Levine AS, Schiöth HB. Feed-forward mechanisms: addiction-like behavioral and molecular adaptations in overeating. Front Neuroendocrinol. 2012 Apr;33(2):127-39.
- Berthoud HR, Lenard NR, Shin AC. Food reward, hyperphagia, and obesity. Am J Physiol Regul Integr Comp Physiol. 2011 Jun;300(6):R1266-77.
- Gout B, Bourges C, Paineau-Dubreuil S. Satiereal, a Crocus sativus L extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women. Nutr Res. 2010 May;30(5):305-13.
- Available at: http://www.mayoclinic.com/health/weight-loss-drugs/WT00013/NSECTIONGROUP=2. Accessed April 22, 2013.
- Lee KU, Lee YM, Nam JM, et al. Antidepressant-induced sexual dysfunction among newer antidepressants in a naturalistic setting. Psychiatry Investig. 2010 Mar;7(1):55-9.
- Kapczinski F, Lima MS, Souza JS, Schmitt R. Antidepressants for generalized anxiety disorder. Cochrane Database Syst Rev. 2003;(2):CD003592.
- Available at: http://www.nice.org.uk/nicemedia/pdf/cg031niceguideline.pdf. Accessed April 22, 2013.
- Available at: http://www.guidelines.gov/content.aspx?id=9318+. Accessed April 22, 2013.
- Landen M, Eriksson E, Agren H, Fahlen T. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol. 1999; 19(3):268-71.
- Gupta S, Droney T, Masand P, Ashton AK. SSRI-induced sexual dysfunction treated with sildenafil. Depress Anxiety. 1999;9(4):180-2.
- Aizenberg D, Zemishlany Z, Weizman A. Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors. Clin Neuropharmacol, 1995;18(4):320-4.
- Clayton AH, McGarvey EL, Abouesh AI, Pinkerton RC. Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction. J Clin Psychiatry. 2001;62(3):185-90.
- Woodrum ST, Brown CS. Management of SSRI-induced sexual dysfunction. Ann Pharmacother. 1998;32(11):1209-15.
- Feder R. Reversal of antidepressant activity of fluoxetine by cyproheptadine in three patients. J Clin Psychiatry. 1991;52(4):163-4.
- Kashani L, Raisi F, Saroukhani S, et al. Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study. Hum Psychopharmacol. 2013 Jan;28(1):54-60.
- Shamsa A, Hosseinzadeh H, Molaei M, Shakeri MT, Rajabi O. Evaluation of Crocus sativus L. (saffron) on male erectile dysfunction: a pilot study. Phytomedicine. 2009;16(8):690-3.
- Hosseinzadeh H, Ziaee T, Sadeghi A. The effect of saffron, Crocus sativus stigma, extract and its constituents, safranal and crocin on sexual behaviors in normal male rats. Phytomedicine. 2008;15(6-7):491-5.
- Available at: http://www.who.int/mediacentre/factsheets/fs297/en/nl. Accessed April 22, 2013.
- Available at: http://preventcancer.aicr.org/site/DocServer/E81-TLPW.pdf?docID=1861. Accessed April 22, 2013.
- Escribano J, Alonso GL, Coca-Prados M, Fernandez JA. Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. Cancer Lett. 1996;100(1-2):22-30.
- Chryssanthi DG, Lamari FN, Iatrou G, Pylara A, Karamanos NK, Cordopatis P. Inhibition of breast cancer cell proliferation by style constituents of different Crocus species. Anticancer Res. 2007;27(1A):357-62.
- Abdullaev JF, Caballero-Ortega H, Riverón-Negrete L, et al. In vitro evaluation of the chemopreventive potential of saffron. Rev Invest Clin. 2002;54(5):430-6.
- Abdullaev FI. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp Biol Med. 2002;227:20-5.
- Nair SC, Salomi MJ, Pannikar. B, Pannikar KR. Modulatory effects of the extracts of saffron and Nigela sativa against cisplatinum induced toxicity in mice. J Ethnopharmacol. 1991;31:75-83.
- el Daly ES. Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats. J Pharm Belg. 1998 Mar-Apr;53(2):87-93; discussion 93-5.
- Hosseinzadeh H, Sadeghnia HR. Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. Jour Pharm Pharmaceut Sci. 2005;8(3):394-9.
- Assimopoulou AN, Sinakos Z, Papageorgiou VP. Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytother Res. 2005 Nov;19(11):997-1000.
- Papandreou MA, Tsachaki M, Efthimiopoulos S, Cordopatis P, Lamari FN, Margarity M. Memory enhancing effects of saffron in aged mice are correlated with antioxidant protection. Behav Brain Res. 2011 Jun 1;219(2):197-204.
- Verma SK, Bordia A. Antioxidant property of saffron in man. Indian J Med Sci. 1998;52:205–7.
- Xuan B, Zhou YH, Li N, Min ZD, Chiou GC. Effects of crocin analogs on ocular blood flow and retinal function. J Ocul Pharmacol Ther. 1999 Apr;15(2):143-52.
- Yamauchi M, Tsuruma K, Imai S, et al. Crocetin prevents retinal degeneration induced by oxidative and endoplasmic reticulum stresses via inhibition of caspase activity. Eur J Pharmacol. 2011 Jan 10;650(1):110-9.
- Maccarone R, Di Marco S, Bisti, S. Saffron supplement maintains morphology and function after exposure to damaging light in mammalian retina. Invest Ophth Visual. 2008 Mar;49(3):1254-61.
- Falsini B, Piccardi M, Minnella A, et al. Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6118-24.
- Moghaddasi MS. Saffron chemicals and medicine usage. Jour Med Plants Res. 2010 Mar 18;4(6):427-30.
- Hosseinzadeh H, Nassiri-Asl M. Avicenna’s (Ibn Sina) the Canon of Medicine and caffron (Crocus sativus): A Review. Phytother Res. 2013 Apr;27(4):475-83.
- Available at: http://www.fdable.com/basic_query/aers/08ced09907b9a949e92270776a382535. Accessed April 22, 2013.
- Feel well + energy
- Slow Food saffron of the best quality (ISO 1), Jiloca, Spain